Company / Book Value per Share
Corvus Pharmaceuticals, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.534
FY2024
5-year range
$0.534 / $2.447
FY2020-FY2024
Trend
-33.7%
vs FY2023
Sector context
#182 of 211
Health Care
What the data says
Corvus Pharmaceuticals, Inc.'s book value per share of $0.534 is lower than 86% of companies in the Health Care sector (FY2024). Book Value per Share has declined for 4 consecutive years, from $2.447 in FY2020 to $0.534 in FY2024.
Based on SEC 10-K filings.
$0.534 in FY2024 with a 5-year CAGR of -26.1%.
Declined from $1.205 to $0.534 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -38.7%
- 5-Year CAGR
- -26.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 211This company $0.534 Sector average $213.854
▼
-99.8% below sector average
Key checks
Key Insights
- Corvus Pharmaceuticals, Inc.'s book value per share has declined for 4 consecutive years.
- 5-year CAGR of -26.1%, indicating a declining trend.
- In FY2024, book value per share decreased 33.7% year-over-year.
- Ranks #182 out of 211 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.534 | -33.7% |
| FY2023 | $0.805 | -33.2% |
| FY2022 | $1.205 | -48.1% |
| FY2021 | $2.321 | -5.1% |
| FY2020 | $2.447 | +1.0% |
| FY2019 | $2.423 | -39.6% |
| FY2018 | $4.011 | -3.1% |
| FY2017 | $4.141 | -51.9% |
| FY2016 | $8.611 | +110.3% |
| FY2015 | -$83.237 | -8814.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026